Neurocrine Biosciences (NBIX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurocrine Biosciences (NBIX)

NBIX 141.70

-4.7%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DewDiligence_on_SI who wrote (1622)	6/25/2006 9:20:23 PM
From: NeuroInvestment	Read Replies (1) of 1834

Generic doxepin is available only as capsules or liquid. Patients may willingly snap a tablet in half, but measuring out half the contents of a capsule, or going through the dilution machinations required for the liquid, is far less likely IMHO. If a generic company decides to start manufacturing a tablet, Somaxon will take that as indicating an intent to make a 'splittable' formulation as a means of poaching...and intends to sue them. Harry NeuroInvestment

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next